CDMOs in Ireland: 8 compared (2026)
8 of the 255 contract development and manufacturing organisations in A4BEE’s European census are headquartered in Ireland. None has revenue over €1bn. 0 sit between €250m and €1bn and 8 are smaller or niche.
By ownership: 4 family-owned, 1 private equity and 3 part of a pharma or industrial group. The most common capabilities are oral solid dose (6), small-molecule API (5), sterile fill-finish (5), biologics and biosimilars (2) and viral vector and vaccine (2). 5 of the 8 rows rest on audited reports or official company disclosures; the rest come from secondary sources or estimates.
8 companies
CDMOs in Ireland
| Company | HQ | Ownership | Size | Revenue (as reported) | Modalities | Data |
|---|---|---|---|---|---|---|
| APC / VLE TherapeuticsIrish-founded (UCD spinout). APC = process-dev/CMC; sister VLE runs the GMP 'factory of the future' — the group has genuine manufacturing. | Dublin | Family-owned | Tier 3 | not disclosed | Small-molecule API, Biologics and biosimilars, Viral vector and vaccine, mRNA and LNP | high |
| BimedaIrish family-owned global animal-health company; contract/private-label veterinary manufacturing (drenches, nutritional liquids, ecto-parasiticides). | Dublin | Family-owned | Tier 3 | not disclosed | Small-molecule API, Sterile fill-finish, Oral solid dose | medium |
| Chanelle PharmaIreland's largest indigenous generics maker (human + veterinary); explicitly offers CMO/CDMO services alongside own generics. | Loughrea | Private equityExponent Private Equity | Tier 3 | not disclosed | Small-molecule API, Oral solid dose, Sterile fill-finish | high |
| EirGen PharmaIrish-HQ specialist HPAPI/oncology OSD CDMO (cytotoxic, genotoxic, steroidal) for external clients. Owned by OPKO (US). | Waterford | Part of a pharma or industrial groupOPKO Health (US) | Tier 3 | not disclosed | Oral solid dose, Small-molecule API | high |
| Helsinn Birex PharmaceuticalsIrish-registered entity primarily making the Swiss parent's products; advertises third-party OSD + gel/cream contract manufacturing. Closer to captive site. | Dublin | Part of a pharma or industrial groupHelsinn Group (Switzerland) | Tier 3 | not disclosed | Oral solid dose, Sterile fill-finish, Small-molecule API | low |
| HiTech HealthFirst Irish company licensed to contract-manufacture cell & gene therapies. End-to-end ATMP CDMO with EU/UK QP release. | Galway | Family-owned | Tier 3 | not disclosed | Cell and gene therapy, Viral vector and vaccine, Biologics and biosimilars | high |
| Ovelle PharmaceuticalsFamily-owned (since 1934). Own dermatology brands plus CMO/CDMO manufacturing of cosmetic, medical-device and licensed products. | Dundalk | Family-owned | Tier 3 | not disclosed | Sterile fill-finish, Oral solid dose | medium |
| Pinewood HealthcareIrish-HQ operating entity with a dedicated contract-manufacturing division (non-beta-lactam sachets/powders, oral liquids, creams). Owned by Wockhardt (India). | Ballymacarbry | Part of a pharma or industrial groupWockhardt (India) | Tier 3 | not disclosed | Oral solid dose, Sterile fill-finish | high |
Size: Tier 1 (revenue over €1bn) · Tier 2 (€250m–€1bn) · Tier 3 (under €250m or niche).
Revenue, staff and site figures are as reported and mix audited accounts with commercial estimates, which are often wrong for private companies. Each row carries a confidence mark; verify a figure before quoting it.
Browse the census
Other European CDMO lists
By country
- CDMOs in Italy (31)
- CDMOs in Spain (30)
- CDMOs in Germany (28)
- CDMOs in the United Kingdom (25)
- CDMOs in France (15)
- CDMOs in Switzerland (14)
- CDMOs in Poland (11)
- CDMOs in Belgium (9)
- CDMOs in Sweden (9)
- CDMOs in Greece (8)
- CDMOs in Ireland
- CDMOs in the Netherlands (8)
- CDMOs in Portugal (8)
- CDMOs in Denmark (7)
- CDMOs in Austria (5)
- CDMOs in Finland (5)
- CDMOs in Norway (5)
- CDMOs in Czechia (4)
- CDMOs in Lithuania (4)
- CDMOs in Bulgaria (3)
By modality
- Small-molecule API CDMOs in Europe (107)
- Oral solid dose CDMOs in Europe (94)
- Sterile fill-finish CDMOs in Europe (106)
- Biologics and biosimilars CDMOs in Europe (66)
- Monoclonal antibody CDMOs in Europe (36)
- Antibody-drug conjugate (ADC) CDMOs in Europe (15)
- Cell and gene therapy CDMOs in Europe (29)
- mRNA and LNP CDMOs in Europe (22)
- Viral vector and vaccine CDMOs in Europe (32)
- Microbial and protein CDMOs in Europe (34)
- Peptide CDMOs in Europe (24)